The Prior Authorization Conversation Is Moving Forward. But Will It Reduce Provider Burden?

What CMS’ proposed drug prior authorization reforms signal for patient services strategy

Prior authorization reform is back in focus.

The Centers for Medicare & Medicaid Services, or CMS, recently proposed new reforms intended to expand electronic prior authorization for drugs, shorten decision timeframes, increase transparency, and reduce administrative burden across federal programs.

Now that the public comment period has closed, the industry is watching what comes next.

That attention is important. Prior authorization has long been one of the most visible access barriers in healthcare, particularly for specialty therapies, medical benefit products, infused products, diagnostics, and complex treatment journeys. When the process is slow, unclear, or fragmented, patients can wait longer to start therapy, providers spend more time managing administrative work, and manufacturers may see access strategies break down at the point of care.

But as the conversation around reform continues, one thing is clear:

Prior authorization is not only a policy issue.

It is a workflow issue.

Faster decisions matter. But speed is only part of the problem.

Much of the prior authorization conversation focuses on turnaround time, and for good reason. Faster decisions can help reduce delays and improve the path to therapy.

But for provider offices, the burden often starts before a decision is ever made.

Office staff may be navigating multiple payer portals, collecting and resubmitting documentation, tracking unclear payer criteria, managing repeated follow-up, and trying to determine where a case stands without real-time visibility.

Even when decision timelines improve, those workflow challenges can remain.

A faster answer is helpful. But if the path to getting that answer still requires manual workarounds, disconnected systems, unclear next steps, and repeated phone calls, the burden has not truly been solved.

This is where patient services strategy becomes critical.

Stakeholder comments point to the same underlying concern: implementation matters.

Early stakeholder comments on CMS’ proposed drug prior authorization reforms appear to reinforce a practical reality: modernization is only meaningful if it works inside real clinical and administrative workflows.

Hospital and provider organizations have emphasized the importance of implementation that aligns with clinical workflows, creates consistent payer behavior, and meaningfully reduces administrative burden. Medical group stakeholders have also focused on the need for interoperability and operational clarity so prior authorization reform can translate into actual improvement for practices.

That distinction matters.

The goal is not simply to make prior authorization electronic.

The goal is to make it easier for patients and providers to navigate.

An electronic process can still create friction if it requires provider teams to enter the same information in multiple places, chase documentation, manually monitor case status, or guess what happens next.

For manufacturers, this creates an important strategic question:

Are patient support programs ready for a more electronic, more transparent prior authorization environment?

Provider workflow is where access friction becomes real.

Patient access delays are often discussed at the payer, policy, or system level. But in practice, many delays are experienced inside provider office workflows.

That is where benefit verification, prior authorization, documentation, appeals, copay support, pharmacy coordination, and patient communication all converge.

For provider teams, the challenge is not always one large barrier. More often, it is a series of smaller friction points that compound:

Multiple portals.

Manual document uploads.

Unclear payer requirements.

Limited case visibility.

Repeated follow-up.

Disconnected reimbursement and pharmacy workflows.

No easy way to know what is missing or what happens next.

Each of these steps can create delay. Together, they can make access feel harder than it needs to be.

That is why reducing provider burden should be viewed as a patient access strategy.

If provider teams have a clearer, easier, more connected experience, patients are more likely to move through the process with fewer avoidable delays.

Manufacturers should not wait for policy to solve workflow problems.

CMS’ proposed reforms may help move the industry toward faster, more electronic prior authorization processes. But manufacturers should not assume policy change alone will solve access friction.

Patient support programs still need infrastructure that can help provider teams navigate the realities of the process today.

That means asking practical questions:

Can provider offices see where a case stands without calling?

Can documentation be submitted easily?

Can missing information be identified quickly?

Can benefit verification, prior authorization, appeals, affordability, and pharmacy coordination be connected?

Can field reimbursement teams access the information they need to support accounts?

Can program teams track where patients are getting stuck?

Can reporting show patterns before they become larger access issues?

These questions matter because prior authorization does not happen in isolation. It is part of a broader patient services ecosystem.

A modern reimbursement support model should not only help complete the required steps. It should make the process easier to manage, easier to see, and easier to improve.

What modern reimbursement support should include

As prior authorization continues to evolve, manufacturers should evaluate whether their patient support programs are built for the next phase of access.

A more connected model should include:

1. Real-time visibility

Provider teams should not have to rely on repeated phone calls or manual follow-up to understand case status. Visibility into enrollment, benefit verification, prior authorization, appeals, and next steps can reduce uncertainty and help offices act faster.

2. Easier documentation

Documentation is one of the most common sources of delay. A modern support model should make it easier for provider teams to submit forms, upload required information, identify missing items, and understand payer-specific requirements.

3. Connected reimbursement workflows

Benefit verification, prior authorization, reauthorization, appeals, and affordability support should not operate as disconnected steps. When workflows are connected, teams can reduce handoffs and improve continuity across the patient journey.

4. Provider-friendly technology

Technology should fit into provider office workflows, not add another layer of complexity. The best systems reduce manual effort, create clarity, and make the user experience more intuitive for office staff.

5. Human expertise where it matters

Automation and electronic prior authorization can improve efficiency, but complex access issues still require experienced reimbursement support. The strongest models combine technology-enabled workflows with knowledgeable teams who understand payer requirements, documentation, appeals, and patient-centered communication.

6. Program data that drives decisions

Manufacturers need more than activity reporting. They need insight into where cases are slowing down, what documentation issues are recurring, which payer trends are emerging, and where provider teams need additional support.

How eMAX Health Patient Services supports this shift

At eMAX Health Patient Services, we believe patient support programs should be built around the realities of access, not just the requirements of a process.

Our approach combines technology-enabled workflows with experienced reimbursement, patient services, pharmacy, quality, and compliance support. Through HealthPACER®, our team helps manufacturers create more connected patient support programs with provider visibility, role-specific interfaces, reimbursement workflow support, reporting, and coordinated access infrastructure.

For manufacturers supporting complex therapies, medical benefit products, specialty products, or evolving hub models, this kind of infrastructure matters.

The industry may be moving toward faster and more electronic prior authorization.

But the opportunity is larger than speed.

The real opportunity is to make access easier to navigate for the people doing the work every day.

The path forward

CMS’ proposed drug prior authorization reforms are an important signal. They reflect continued momentum toward a more electronic, transparent, and efficient access environment.

But the success of prior authorization reform will ultimately depend on what happens inside day-to-day workflows.

For provider offices, the question is not only whether decisions come faster.

It is whether the process becomes easier to manage.

For manufacturers, the question is whether their patient support programs are ready to support that shift.

Faster decisions matter.

So does visibility.

So does documentation.

So does human support.

So does the workflow behind it all.

As prior authorization continues to evolve, manufacturers have an opportunity to rethink reimbursement support as a critical part of patient access infrastructure.

At eMAX Health Patient Services, we help manufacturers build connected support models that reduce friction, improve visibility, and support a better experience for providers and patients.

Is your patient support program ready for what comes next in prior authorization?

Contact eMAX Health Patient Services to start the conversation.